Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma - MORSECRC

Autor: ARMIN GERGER, WOLFGANG EISTERER, STEFAN FUXIUS, SARA BASTIAN, DIETER KOEBERLE, MANFRED WELSLAU, DILARA AKHOUNDOVA SANOYAN, CHRISTIAN MAAS, JENS UHLIG, KLAUS FENCHEL, RICHARD GREIL, EYCK VON DER HEYDE, GAËLLE RHYNER AGOCS, RUDOLF WEIDE, MONIKA SCHWAGER, FRANK REICHENBACH, DOMINIK PAUL MODEST, RALPH FRITSCH

Publikováno v: Gerger, Armin; Eisterer, Wolfgang; Fuxius, Stefan; Bastian, Sara; Koeberle, Dieter; Welslau, Manfred; Akhoundova Sanoyan, Dilara; Maas, Christian; Uhlig, Jens; Fenchel, Klaus; Greil, Richard; von der Heyde, Eyck; Rhyner Agocs, Gaëlle; Weide, Rudolf; Schwager, Monika; Reichenbach, Frank; Modest, Dominik Paul; Fritsch, Ralph (2022). Retrospective Analysis of Treatment Pathways in Patients With BRAFV600E-mutant Metastatic Colorectal Carcinoma-MORSECRC. Anticancer research, 42(10), pp. 4773-4785. International Inst. of Anticancer Research 10.21873/anticanres.15982

BACKGROUND/AIM Metastatic colorectal cancer (mCRC) is a heterogeneous disease with distinct molecular subtypes. The BRAFV600E-mutation found in approximately 8-12% of mCRC patients is associated with poor prognosis. Guideline recommendations for this

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2790dec295899d86fd9bcfece5d03e6f

[Immunotherapy: also in elderly patients ?]

Autor: Gaëlle, Rhyner Agocs, Vérène, Dougoud-Chauvin, Daniel, Betticher

Publikováno v: Revue medicale suisse. 15(660)

The emergence of immunotherapy has generated great enthusiasm in oncology improving the prognosis of pathologies such as melanoma, lung cancer, kidney cancer, bladder and head and neck cancers. This enthusiasm concerns also older patients in view of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cc8aeea46d1402fce2a84c307870b7be
https://pubmed.ncbi.nlm.nih.gov/31496176